valine and p-aminohippuric acid

valine has been researched along with p-aminohippuric acid in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Balimane, PV; Sinko, PJ1
Bünten, B; Grabensee, B; Németh, R; Plum, J1
Biggi, A; Cabassi, A; De Iaco, G; Iori, M; Magnani, G; Montanari, A; Musiari, L; Novarini, A; Pelà, GM; Pelloni, I; Pinelli, S1

Trials

2 trial(s) available for valine and p-aminohippuric acid

ArticleYear
Effects of the angiotensin II antagonist valsartan on blood pressure, proteinuria, and renal hemodynamics in patients with chronic renal failure and hypertension.
    Journal of the American Society of Nephrology : JASN, 1998, Volume: 9, Issue:12

    Topics: Aged; Albuminuria; Angiotensin II; Antihypertensive Agents; Blood Pressure; Blood Urea Nitrogen; Creatinine; Dextrans; Double-Blind Method; Erythrocyte Count; Female; Glomerular Filtration Rate; Humans; Hypertension, Renal; Inulin; Kidney Failure, Chronic; Kidney Glomerulus; Male; Middle Aged; Molecular Weight; p-Aminohippuric Acid; Particle Size; Potassium; Prospective Studies; Proteinuria; Renal Circulation; Tetrazoles; Valine; Valsartan

1998
Contribution of bradykinin B2 receptors to the inhibition by valsartan of systemic and renal effects of exogenous angiotensin II in salt-repleted humans.
    The Journal of pharmacology and experimental therapeutics, 2010, Sep-01, Volume: 334, Issue:3

    Topics: Adrenergic beta-Antagonists; Adult; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Bradykinin; Bradykinin B2 Receptor Antagonists; Female; Glomerular Filtration Rate; Humans; Indicators and Reagents; Inulin; Kidney; Male; p-Aminohippuric Acid; Receptor, Bradykinin B2; Renal Circulation; Sodium; Tetrazoles; Valine; Valsartan

2010

Other Studies

1 other study(ies) available for valine and p-aminohippuric acid

ArticleYear
Carrier-mediated intestinal absorption of valacyclovir, the L-valyl ester prodrug of acyclovir: 1. Interactions with peptides, organic anions and organic cations in rats.
    Biopharmaceutics & drug disposition, 1998, Volume: 19, Issue:4

    Topics: Acyclovir; Animals; Anions; Antiviral Agents; Buffers; Cations; Drug Carriers; Drug Interactions; Drug Stability; Intestinal Absorption; Male; p-Aminohippuric Acid; Peptides; Perfusion; Prodrugs; Quinine; Rats; Rats, Sprague-Dawley; Valacyclovir; Valine

1998